In all, our results indicate that overexpression of Sna TFs specifically in the cardiomyocytes promotes the development of obesity and insulin resistance, lipid metabolic phenotypes that are opposite to those seen with the inhibition of Sna TFs in the heart (Fig 1). The gene discussed is SNAI1; the disease is Insulin resistance.